SCS Capital Management’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17M Sell
2,934,579
-21,580
-0.7% -$135K 0.16% 83
2026
Q1
$17.9M Sell
2,956,159
-137,856
-4% -$807K 0.19% 67
2025
Q4
$21.5M Sell
3,094,015
-50,014
-2% -$356K 0.23% 65
2025
Q3
$23M Sell
3,144,029
-1,177,241
-27% -$8.59M 0.25% 62
2025
Q2
$26.4M Sell
4,321,270
-505,903
-10% -$2.34M 0.29% 55
2025
Q1
$15.1M Buy
+4,827,173
New +$16.9M 0.19% 66

Other funds holding EVLV

SCS Capital Management's EVLV Position: Q2 2026 in Review

SCS Capital Management reduced its Evolv Technologies (EVLV) stake by 0.73% in Q2 2026, selling an estimated $135K and leaving 2,934,579 shares worth $17M. The position accounts for 0.16% of the portfolio, ranked #83.

SCS Capital Management first reported a position in EVLV in Q1 2025 and has held it in 6 quarters since. The position peaked at $26.4M in Q2 2025. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • SCS Capital Management held 2,934,579 shares of Evolv Technologies worth $17M as of Q2 2026.
  • SCS Capital Management sold 21,580 Evolv Technologies shares in Q2 2026, an estimated $135K.
  • Evolv Technologies made up 0.16% of SCS Capital Management's portfolio in Q2 2026, its #83 holding.
  • SCS Capital Management first reported a position in Evolv Technologies in Q1 2025 and has held it in 6 quarters since.
  • SCS Capital Management's Evolv Technologies position peaked at $26.4M in Q2 2025.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.